ISSN: 0961-2033
Journal Home
Journal Guideline
Lupus Q2 Unclaimed
Lupus is a journal indexed in SJR in Rheumatology with an H index of 114. It has an SJR impact factor of 0,822 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,822.
Lupus focuses its scope in these topics and keywords: lupus, systemic, erythematosus, response, review, antiphospholipid, syndrome, presenting, evaluation, japanintestinal, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,822
SJR Impact factor114
H Index210
Total Docs (Last Year)765
Total Docs (3 years)6823
Total Refs1876
Total Cites (3 years)699
Citable Docs (3 years)2.25
Cites/Doc (2 years)32.49
Ref/DocOther journals with similar parameters
Revmatologiia Q2
Revmatologiia (Bulgaria) Q2
Rheumatology International Q2
Clinical and Experimental Rheumatology Q2
Joint Bone Spine Q2
Compare this journals
Aims and Scope
Best articles by citations
Dobutamine stress echocardiography in women with systemic lupus erythematosus: increased occurrence of left ventricular outflow gradient
View moreResponsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus
View moreMultitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis
View moreAnti-beta2-glycoprotein I Antibody: Specificity and Clinical Significance
View moreEffector and predisposing genes in murine lupus
View moreClinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus
View moreFlares in lupus nephritis: Incidence, impact on renal survival and management
View morePolymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus
View moreMucocutaneous disease in Arabs with systemic lupus erythematosus: Clinical expression and relevance to autoantibodies
View moreGenetic susceptibility to lupus nephritis
View moreExpression of complement regulatory proteins in diffuse proliferative glomerulonephritis
View moreMembers of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis
View moreOutcome criteria for lupus nephritis trials: A critical overview
View moreImpaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells
View moreProduction of pathogenic antibodies: Cognate interactions between autoimmune T and B cells
View moreDecreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients
View moreProlactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity
View moreRole of HLA in congenital heart block: susceptibility alleles in mothers
View moreFactors associated with chloroquine-induced retinopathy in rheumatic diseases
View moreProlactin in rheumatoid arthritis
View moreProlactin levels and antinuclear antibody profiles in women tested for connective tissue disease
View moreSystemic lupus erythematosus presenting as acute symptomatic hypercalcemia
View moreLupus and the nervous system
View moreSystemic lupus erythematosus with hepatic aneurysm, Valsalva sinus aneurysm and associated polyangiitis: aneurysmal wall remodeling with dense fibrosis and calcification mediated by residual smooth muscle cells
View more
Comments